ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
Mr Jones
|
129 |
37K |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
129
|
37K
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
Mr Jones
|
9.4K |
3.9M |
12 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
9.4K
|
3.9M
|
12
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Mr Jones
|
1.0K |
317K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
1.0K
|
317K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics CEO announces retirement
|
|
Mr Jones
|
204 |
70K |
7 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
204
|
70K
|
7
|
|
ASX - By Stock
|
WHC Coal |
Re:
Projected FY 2021-22 and Final dividends
|
|
Mr Jones
|
287 |
169K |
3 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
287
|
169K
|
3
|
|
ASX - By Stock
|
PER |
Re:
atl1102 in the Box seat re DMD. Sarepta fails .
|
|
Mr Jones
|
114 |
31K |
1 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
114
|
31K
|
1
|
|
ASX - By Stock
|
WHC |
Re:
Target $4.61
|
|
Mr Jones
|
6.8K |
2.2M |
0 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
6.8K
|
2.2M
|
0
|
|
ASX - By Stock
|
PER |
Re:
AGM on now
|
|
Mr Jones
|
78 |
23K |
8 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
78
|
23K
|
8
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Mr Jones
|
855 |
245K |
16 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
245K
|
16
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Mr Jones
|
855 |
245K |
16 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
245K
|
16
|
|
Charts
|
PER |
Re:
Chart
|
|
Mr Jones
|
5.9K |
2.3M |
1 |
20/10/21 |
20/10/21 |
Charts
|
5.9K
|
2.3M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
Mr Jones
|
10K |
3.7M |
6 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
10K
|
3.7M
|
6
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
8 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
32K
|
14M
|
8
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
5 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
32K
|
14M
|
5
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
Mr Jones
|
10K |
3.7M |
8 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
10K
|
3.7M
|
8
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
32K
|
14M
|
5
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
32K
|
14M
|
2
|
|
Charts
|
PER |
Re:
Chart
|
|
Mr Jones
|
5.9K |
2.3M |
5 |
05/02/21 |
05/02/21 |
Charts
|
5.9K
|
2.3M
|
5
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Change of Director's Interest
|
|
Mr Jones
|
133 |
45K |
22 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
133
|
45K
|
22
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
3 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
32K
|
14M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Proposed issue of Securities - ANP
|
|
Mr Jones
|
79 |
27K |
12 |
30/01/21 |
30/01/21 |
ASX - By Stock
|
79
|
27K
|
12
|
|
ASX - By Stock
|
WBT |
Re:
Weebit Nano Options - WBTOA
|
|
Mr Jones
|
34 |
14K |
4 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
34
|
14K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
Mr Jones
|
32K |
14M |
0 |
28/12/20 |
28/12/20 |
ASX - By Stock
|
32K
|
14M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: 2020 Annual General Meeting Presentation
|
|
Mr Jones
|
72 |
24K |
9 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
72
|
24K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: 2020 Annual General Meeting Presentation
|
|
Mr Jones
|
72 |
24K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
72
|
24K
|
1
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Change in Director's Interest Notice
|
|
Mr Jones
|
123 |
31K |
28 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
123
|
31K
|
28
|
|
ASX - By Stock
|
PER |
Re:
taking up the offer at 10c?
|
|
Mr Jones
|
26 |
7.3K |
8 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
26
|
7.3K
|
8
|
|
ASX - By Stock
|
PER |
Re:
AGM
|
|
Mr Jones
|
70 |
15K |
3 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
70
|
15K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP receives US FDA ODD for ATL1102 in DMD
|
|
Mr Jones
|
23 |
8.2K |
2 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
23
|
8.2K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
Mr Jones
|
97 |
24K |
1 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
97
|
24K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder from AEF
|
|
Mr Jones
|
44 |
9.2K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
44
|
9.2K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder from AEF
|
|
Mr Jones
|
44 |
9.2K |
1 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
44
|
9.2K
|
1
|
|
ASX - By Stock
|
PER Biotech |
Re:
Research report
|
|
Mr Jones
|
52 |
13K |
5 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
52
|
13K
|
5
|
|
ASX - By Stock
|
WHC |
Re:
IBES Report in - WHC is a Buy
|
|
Mr Jones
|
1.2K |
399K |
3 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
1.2K
|
399K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Mr Jones
|
44 |
14K |
7 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
44
|
14K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Mr Jones
|
44 |
14K |
1 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
44
|
14K
|
1
|
|
ASX - By Stock
|
PER |
Re:
The Rome Cohort
|
|
Mr Jones
|
80 |
19K |
3 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
80
|
19K
|
3
|
|
ASX - By Stock
|
PER |
Re:
The Rome Cohort
|
|
Mr Jones
|
80 |
19K |
6 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
80
|
19K
|
6
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Board Appointment & Sales Incentive
|
|
Mr Jones
|
155 |
45K |
4 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
155
|
45K
|
4
|
|
ASX - By Stock
|
PER |
Re:
The Rome Cohort
|
|
Mr Jones
|
80 |
19K |
3 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
80
|
19K
|
3
|
|
ASX - By Stock
|
PER |
Re:
The Rome Cohort
|
|
Mr Jones
|
80 |
19K |
3 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
80
|
19K
|
3
|
|
ASX - By Stock
|
PER |
Re:
An FDA Act that may be relvant to ATL-1102 FDA
|
|
Mr Jones
|
210 |
63K |
3 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
210
|
63K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Mr Jones
|
125 |
33K |
6 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
125
|
33K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change in Substantial Holding from AEF
|
|
Mr Jones
|
5 |
1.9K |
5 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
5
|
1.9K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Mr Jones
|
125 |
33K |
6 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
125
|
33K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Mr Jones
|
125 |
33K |
5 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
125
|
33K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Mr Jones
|
125 |
33K |
3 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
125
|
33K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
Mr Jones
|
109 |
30K |
4 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
109
|
30K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
Mr Jones
|
109 |
30K |
1 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
109
|
30K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Mr Jones
|
71 |
23K |
1 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
71
|
23K
|
1
|
|